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Background
Allergen-specific IgE testing is usually performed with
crude peanut extract, and peanut specific IgE-levels are
associated with the probability to react at peanut expo-
sure, but cannot predict severity of symptoms. The aim
of this study was to investigate levels of IgE to the more
clinically relevant peanut allergen component Ara h 2 in
children in relation to severity of symptoms.
Methods
From a birth cohort of 4089 children clinical parameters
were obtained through questionnaires. At eight years of age
follow up IgE antibody levels between 0.35 and 100 kU/L to
peanut extract and peanut allergen components Ara h 1,
Ara h 2 and Ara h 3 were measuredusing ImmunoCAP
method. Questionnaire data on reactions from peanut was
used from both the eight and 12 years of age questionnaire
Results
Of the 2461 tested children (60% of the original cohort)
195 (7.9%) exhibited IgE to peanut extract above cut off
(0.35 kU/L). 185 of those were also analysed for Ara h
1, h2 and h 3 IgE. Peanut symptoms were reported in
70 (82%) of the 85 children with IgE to Ara h 2 at eight
years and 75% at 12 years. Type of symptoms at peanut
exposure were plotted in relation to peanut Ara h 2
IgE-level. Children with systemic symptoms (GI/urti-
caria/breathing) to peanut at eight years of age had
higher IgE-levels to Ara h 2 (median 27 kU/L) than chil-
dren with only local symptoms from mouth, eye or nose
(median level 0.77 kU/L), p=0.0065. To include Ara h 1
and h 3 in the analysis did not change the results. Four
children with rather high Ara h 2 IgE levels, but with no
or mild symptoms at eight years reported more severe
symptoms at 12 years.
Conclusion
High IgE-levels to peanut allergen component Ara h 2
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